SEIGY yields 3.75% · JNJ yields 2.13%● Live data
📍 SEIGY pulled ahead of the other in Year 1
Combined, SEIGY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEIGY + JNJ for your $10,000?
Semperit Aktiengesellschaft Holding develops, produces, and sells rubber products for the medical and industrial sectors worldwide. It operates through five segments: Sempermed, Semperflex, Sempertrans, Semperform, and Semperseal. The Sempermed segment manufactures examination and surgical gloves in the medical area, as well as protective gloves for industrial, commercial, and private use. The Semperflex segment develops, produces, and sells hydraulic and industrial hoses that are used in the construction and transport industry, as well as in mining; and agricultural machinery. The Sempertrans segment provides textile and steel-cord conveyor belts for use in mining, steel, cement, civil engineering, and transport industries, as well as in power stations. The Semperform segment offers escalator handrails; ropeway rubber rings; anti-vibration membranes for skis and snowboards; and customised injection moulding and extrusion parts with sealing or damping functions. The Semperseal segment provides elastomer and sealing profiles for windows, doors, and facades; and elastomer and wear-resistant protective sheeting. The company was founded in 1824 and is headquartered in Vienna, Austria.
Full SEIGY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.